高级搜索

VEGF抑制剂的抗肿瘤相关常见不良反应及其干预策略

VEGF Inhibitor–Associated Side Effects in Antitumor Therapy and Intervention Strategies

  • 摘要: 血管内皮生长因子(VEGF)抑制剂是一类靶向抑制肿瘤血管生成的药物,通过阻断VEGF及其受体的信号通路来抑制肿瘤增殖,在肿瘤治疗中发挥了重要作用。然而,其治疗过程中的相关不良反应严重影响患者治疗依从性和生存质量,甚至导致治疗中断。因此探索VEGF抑制剂不良反应的干预策略对肿瘤治疗具有重要意义。本文就VEGF抑制剂在肿瘤治疗过程中导致的高血压、蛋白尿、手足皮肤反应和骨髓抑制等常见不良反应的临床特征和毒性机制等展开综述,并总结了针对性的中西医结合干预策略。精准监测、调整药物剂量以达到抗肿瘤的目的,采用益气活血、健脾补肾等中药针对性地改善患者不适症状,中西药协同救治患者,为肿瘤患者提供更安全有效的治疗方案。

     

    Abstract: Vascular endothelial growth factor (VEGF) inhibitors are drugs that target and inhibit tumor angiogenesis. By blocking the signaling pathway of VEGF and its receptor, they suppress tumor proliferation and play a crucial role in tumor treatment. However, their side effects, such as hypertension, proteinuria, hand-foot skin reactions, and myelosuppression, during treatment seriously affect patients' treatment compliance and quality of life. The development of intervention strategies for the side effects of VEGF inhibitors is of great importance for tumor treatment. This article reviews the clinical characteristics and toxic mechanisms of common side effects caused by VEGF inhibitors during tumor treatment and summarizes intervention strategies that combine traditional Chinese and Western medicines. Drug dosages were precisely monitored and adjusted to achieve antitumor treatment. Patients' discomfort symptoms are improved through prescriptions that act by tonifying qi and promoting blood circulation, strengthening the spleen, and tonifying the kidney. The combination of traditional Chinese and Western medicines is used to treat patients, thus providing a safe and effective treatment plan for patients with cancer.

     

/

返回文章
返回